Organization type,Participants
Regulatory agencies and standard setting agencies,"Paul-Ehrlich-Institut (PEI, Germany), U.S. Food and Drug Administration, Center for Biologics Evaluation and Research (U.S. FDA/CBER, USA), National Institute for Biological Standards and Control (NIBSC, UK), Health Canada (Canada), Therapeutic Goods Administration (TGA, Australia), National Institute of Biologicals (NOIDA, India), European Directorate for the Quality of Medicines (EDQM), United States Pharmacopoeia (USP)"
Patient and professional organizations,"World Federation of Haemophilia (WFH), UK Haemophilia Doctors' Organisation (UKHDO) and The International Society on Thrombosis and Haemostasis (ISTH)"
Industry                        Industry organizations                        FVIII and FIX Manufacturers,"International Plasma Fractionation Association (IPFA) and Plasma Protein Therapeutics Association (PPTA)                        CSL Behring, Novo Nordisk, Octapharma, Sanofi, Takeda, Shandong and Genentech"
IVD manufacturers,"Rossix, Stago, Technoclone, Werfen, Enzyre"
Clinical laboratories,"External quality Control of diagnostic Assays and Tests (ECAT), External Quality Assurance in Thrombosis and Hemostasis (EQATH), North American Specialized Coagulation Laboratory Association (NASCOLA), UK National External Quality Assurance Scheme (UK NEQAS)"
